IL115299A0 - Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use - Google Patents
Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and useInfo
- Publication number
- IL115299A0 IL115299A0 IL11529995A IL11529995A IL115299A0 IL 115299 A0 IL115299 A0 IL 115299A0 IL 11529995 A IL11529995 A IL 11529995A IL 11529995 A IL11529995 A IL 11529995A IL 115299 A0 IL115299 A0 IL 115299A0
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- independently
- preparation
- pox
- hydrogen
- Prior art date
Links
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical class C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002883 imidazolyl group Chemical group 0.000 abstract 2
- NBXOKUUXBOFVIJ-UHFFFAOYSA-N 2h-[1,2,4]triazolo[4,3-a]quinoxalin-1-one Chemical class C1=CC=C2N3C(=O)NN=C3C=NC2=C1 NBXOKUUXBOFVIJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000002964 excitative effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 239000002858 neurotransmitter agent Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106694 | 1994-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL115299A0 true IL115299A0 (en) | 1995-12-31 |
Family
ID=8100607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11529995A IL115299A0 (en) | 1994-09-16 | 1995-09-14 | Ú1, 2, 4¾Triazolo Ú4, 3-a¾ quinoxalinone derivatives their preparation and use |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0781282B1 (xx) |
| JP (1) | JPH10506620A (xx) |
| KR (1) | KR970706285A (xx) |
| CN (1) | CN1193973A (xx) |
| AT (1) | ATE183186T1 (xx) |
| AU (1) | AU694554B2 (xx) |
| CA (1) | CA2200056A1 (xx) |
| CZ (1) | CZ284930B6 (xx) |
| DE (1) | DE69511420T2 (xx) |
| DK (1) | DK0781282T3 (xx) |
| ES (1) | ES2138233T3 (xx) |
| FI (1) | FI971076A (xx) |
| GR (1) | GR3031788T3 (xx) |
| HU (1) | HUT76802A (xx) |
| IL (1) | IL115299A0 (xx) |
| NO (1) | NO308797B1 (xx) |
| NZ (1) | NZ292108A (xx) |
| PL (1) | PL319175A1 (xx) |
| SK (1) | SK282457B6 (xx) |
| TW (1) | TW397835B (xx) |
| WO (1) | WO1996008493A1 (xx) |
| ZA (1) | ZA957794B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| CN1285834A (zh) | 1997-11-11 | 2001-02-28 | 小野药品工业株式会社 | 稠合吡嗪化合物 |
| ES2612954T3 (es) | 2009-03-05 | 2017-05-19 | Astellas Pharma Inc. | Compuestos de quinoxalina |
| PT2615096T (pt) | 2010-09-07 | 2019-10-15 | Astellas Pharma Inc | Composto de quinoxalina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
| WO1993020077A1 (en) * | 1992-04-03 | 1993-10-14 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
| DK31093D0 (xx) * | 1993-03-19 | 1993-03-19 | Novo Nordisk As | |
| KR100304177B1 (ko) * | 1993-05-06 | 2001-11-22 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | (1,2,4)트리아졸로(4,3-a)퀴녹살린화합물,이의제조방법및이를함유하는약제학적조성물_ |
-
1995
- 1995-09-12 CN CN95195697A patent/CN1193973A/zh active Pending
- 1995-09-12 DK DK95930410T patent/DK0781282T3/da active
- 1995-09-12 CA CA002200056A patent/CA2200056A1/en not_active Abandoned
- 1995-09-12 TW TW084109492A patent/TW397835B/zh not_active IP Right Cessation
- 1995-09-12 DE DE69511420T patent/DE69511420T2/de not_active Expired - Fee Related
- 1995-09-12 KR KR1019970701669A patent/KR970706285A/ko not_active Application Discontinuation
- 1995-09-12 WO PCT/DK1995/000365 patent/WO1996008493A1/en not_active Application Discontinuation
- 1995-09-12 SK SK334-97A patent/SK282457B6/sk unknown
- 1995-09-12 AU AU33808/95A patent/AU694554B2/en not_active Ceased
- 1995-09-12 EP EP95930410A patent/EP0781282B1/en not_active Expired - Lifetime
- 1995-09-12 HU HU9701241A patent/HUT76802A/hu unknown
- 1995-09-12 PL PL95319175A patent/PL319175A1/xx unknown
- 1995-09-12 ES ES95930410T patent/ES2138233T3/es not_active Expired - Lifetime
- 1995-09-12 AT AT95930410T patent/ATE183186T1/de not_active IP Right Cessation
- 1995-09-12 JP JP8509828A patent/JPH10506620A/ja active Pending
- 1995-09-12 CZ CZ97753A patent/CZ284930B6/cs not_active IP Right Cessation
- 1995-09-12 NZ NZ292108A patent/NZ292108A/xx unknown
- 1995-09-14 IL IL11529995A patent/IL115299A0/xx unknown
- 1995-09-15 ZA ZA957794A patent/ZA957794B/xx unknown
-
1997
- 1997-03-14 FI FI971076A patent/FI971076A/fi unknown
- 1997-03-14 NO NO971187A patent/NO308797B1/no not_active IP Right Cessation
-
1999
- 1999-11-09 GR GR990402881T patent/GR3031788T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO971187D0 (no) | 1997-03-14 |
| NZ292108A (en) | 1999-02-25 |
| CN1193973A (zh) | 1998-09-23 |
| DK0781282T3 (da) | 2000-02-28 |
| CZ284930B6 (cs) | 1999-04-14 |
| SK33497A3 (en) | 1998-02-04 |
| CZ75397A3 (en) | 1997-08-13 |
| NO308797B1 (no) | 2000-10-30 |
| HUT76802A (en) | 1997-11-28 |
| DE69511420T2 (de) | 2000-03-30 |
| KR970706285A (ko) | 1997-11-03 |
| ZA957794B (en) | 1996-05-14 |
| ATE183186T1 (de) | 1999-08-15 |
| FI971076A0 (fi) | 1997-03-14 |
| SK282457B6 (sk) | 2002-02-05 |
| AU3380895A (en) | 1996-03-29 |
| PL319175A1 (en) | 1997-08-04 |
| TW397835B (en) | 2000-07-11 |
| EP0781282A1 (en) | 1997-07-02 |
| WO1996008493A1 (en) | 1996-03-21 |
| GR3031788T3 (en) | 2000-02-29 |
| EP0781282B1 (en) | 1999-08-11 |
| NO971187L (no) | 1997-05-15 |
| AU694554B2 (en) | 1998-07-23 |
| ES2138233T3 (es) | 2000-01-01 |
| JPH10506620A (ja) | 1998-06-30 |
| FI971076A (fi) | 1997-05-13 |
| DE69511420D1 (de) | 1999-09-16 |
| CA2200056A1 (en) | 1996-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL139056A0 (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| CA2085733A1 (en) | Polycyclic guanine derivatives | |
| NZ312665A (en) | Rrolopyrimidines(7h-pyrrolo[2,3-d]pyrimidine and preparation of these | |
| HUP0001993A2 (hu) | Fungicid hatású (trifluor-metil-alkil)-amino-triazol 0[1,5-a]pirimidin-származékok, előállításuk és alkalmazásuk | |
| ATE179698T1 (de) | Pyrrolidin- und oxazolidin derivate , ihre herstellung und ihre verwendung als thrombocyten- aggregations-hemmer | |
| PL338339A1 (en) | Novel derivatives of tetrazole | |
| IL118167A0 (en) | Pyrazolo (1,5a) pyrimidines their preparation and use | |
| DE60127845D1 (de) | Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel | |
| AU4205197A (en) | New thiazole derivatives with phosphodiesterase-inhibiting effect | |
| PL356541A1 (en) | 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity | |
| GR3031788T3 (en) | [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE | |
| DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| TW216795B (en) | 3-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazoline derivatives, the preparation and use thereof | |
| TR200100133T2 (tr) | FKBP İnhibitörleri | |
| CA2120782A1 (en) | Thioxanthenone antitumor agents | |
| TW334340B (en) | Preparation for pyrazolyl derivatives | |
| GR3033642T3 (en) | [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE | |
| CA2070799A1 (en) | Thioxanthenone antitumor agents | |
| ZA931099B (en) | Heterocyclic compounds their use and preparation | |
| DE60003560D1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| TR199801683A2 (xx) | Yeni �re t�revleri. | |
| IL169334A0 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors |